(NYSEMKT: ISR) Late stage biotech, new product launch coming this summer. Chart reversal- ISR has a breakthrough therapy in oncology already being used in prostate cancer patients, with good and increasing revenues. just starting to get attention here- https://mailchi.mp/broadstreetalerts/late-sta...n-89925?e=[UNIQID]